Search Results 221-230 of 17402 for hba1c

  1. A Study to Evaluate the Safety and Effectiveness of Felzartamab in IgA Nephropathy - Mayo Clinic

    Participation eligibility · Glycated hemoglobin (HbA1c) < 8.0% or < 64 mmoL/mol.; · No diabetic retinopathy known; · No peripheral neuropathy known.

  2. Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States - Mayo Clinic

    Uncontrolled diabetes (HbA1c ≥ 9.0%) within past 24 weeks 17. Kidney function abnormalities including: a. Dialysis b. Baseline epidermal growth factor ...

  3. A study to test whether survodutide helps people with a liver disease called NASH/MASH who have moderate or advanced liver fibrosis - Mayo Clinic

    HbA1c > 10% (> 86 mmol/mol) as measured by the central laboratory at screening. Impaired renal function, defined as eGFR 2x ULN as measured by the central ...

  4. Diabetes: Testing for Early Indicators - Mayo Clinic News Network

    Many people first learn they have diabetes through blood tests done for another condition or as part of a routine physical exam. But in some cases, ...

  5. Diabetes - Doctors and departments - Mayo Clinic

    Learn more about the different types of this blood sugar disorder, who's at risk and how each type can be treated.

  6. Exercise and Low-Dose Rapamycin in Older Adults with CAD:Cardiac Rehabilitation And Rapamycin in Elderly (CARE) Trial - Mayo Clinic

    HbA1c > 13%. Any malignancy; Hematological disorder, including thrombocytopenia, leucopenia. Noncardiac illness expected to limit survival. Chronic liver ...

  7. A Study to Evaluate RheOx Bronchial Rheoplasty System to Treat Chronic Bronchitis in Adults with COPD - Mayo Clinic

    within the past 6 months, uncontrolled diabetes (HbA1c >8%), uncontrolled hypertension (diastolic BP >100mmHg) or autoimmune disease requiring treatment ...

  8. Diabetes - Doctors and departments - Mayo Clinic

    Learn more about the different types of this blood sugar disorder, who's at risk and how each type can be treated.

  9. An Efficacy, Safety and Tolerability Study of Ixmyelocel-T Administered via Transendocardial Catheter-based Injections to Subjects with Heart Failure Due to Ischemic Dilated Cardiomyopathy (IDCM) - Mayo Clinic

    Hemoglobin A1c (HbA1c) ≥ 9% at screening; Diabetic subjects with uncontrolled or untreated proliferative retinopathy as determined by dilated eye exam ...

  10. A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer (ASCLEPIuS) - Mayo Clinic

    Uncontrolled diabetes or known HbA1c\>10 17. Any gastrointestinal disorder affecting absorption 18. Active pituitary or adrenal dysfunction 19. Patients ...